R.PR
REGISTERED-PRINCIPAL REGISTER
01/25/2022
Back to search
Official data from USPTO
NBTX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
01/25/2022
Trademark type
Word
Nice classes
5, 10
Filing date
07/11/2020
Registration date
01/25/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/25/2022
Last transaction
01/25/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
99
Owner location
Paris, FR
Examiner
ADEYIGA,ADETAYO JANET
Law office
M10
Current location
TMO LAW OFFICE 110
Holders and representatives
Holders
Nanobiotix
Representatives
James R Menker HOLLEY & MENKER, PA
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical productspreparations for medical use particularly for the diagnosis and treatment of tumors; pharmaceutical productspreparations for medical use particularly for the diagnosis and treatment of tumors using radiotherapy; pharmaceutical productspreparations for medical use particularly for the diagnosis and treatment of tumors using radiotherapy and immunotherapy; X-ray enhancing agents for medical use for the diagnosis and treatment of tumors using radiotherapyradioenhancers; X-ray contrast agents for medical use for the diagnosis and treatment of tumors using radiotherapyradioenhancers; health goodspharmaceutical preparations for the treatment of tumors using radiotherapy and for the treatment of tumors using radiotherapy and immunotherapy; radiological contrast substances for medical use; nanoparticles for medical use; biological preparations with metallic nanoparticles and/or metal oxides for medical use; chemical preparations with metallic nanoparticles and/or metal oxides for medical or pharmaceutical use; medicinal productsradioenhancers based on metallic nanoparticles and/or metal oxides for medical use for human medicine; chemical pharmaceutical products with metallic nanoparticles and/or metal oxides for the diagnosis of cancer
Class 10
Injectable medical device containing inert metal for the diagnosis and treatment of tumors
Publications
History of USPTO decisions and trademark events.
25 publications found
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/09/2021
PUBO
PUBLISHED FOR OPPOSITION
11/09/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/20/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/04/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
10/04/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/04/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
10/04/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/04/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/04/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/04/2021
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
09/27/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
07/09/2021
GNSL
LETTER OF SUSPENSION E-MAILED
07/09/2021
CNSL
SUSPENSION LETTER WRITTEN
07/09/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/25/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/25/2021
ALIE
ASSIGNED TO LIE
06/22/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/08/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/08/2020
GNRT
NON-FINAL ACTION E-MAILED
10/08/2020
CNRT
NON-FINAL ACTION WRITTEN
10/08/2020
DOCK
ASSIGNED TO EXAMINER
10/06/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/08/2020
NWAP
NEW APPLICATION ENTERED
07/15/2020
Continuous trademark protection
Get notified about every new filing that threatens NBTX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.